FR2437401A1 - Analogues cycliques de la callidine et leur application therapeutique - Google Patents

Analogues cycliques de la callidine et leur application therapeutique

Info

Publication number
FR2437401A1
FR2437401A1 FR7924399A FR7924399A FR2437401A1 FR 2437401 A1 FR2437401 A1 FR 2437401A1 FR 7924399 A FR7924399 A FR 7924399A FR 7924399 A FR7924399 A FR 7924399A FR 2437401 A1 FR2437401 A1 FR 2437401A1
Authority
FR
France
Prior art keywords
callidine
remainder
cyclic
arginine
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7924399A
Other languages
English (en)
Other versions
FR2437401B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST ORGANICHESKOGO SINTEZA AK
Original Assignee
INST ORGANICHESKOGO SINTEZA AK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST ORGANICHESKOGO SINTEZA AK filed Critical INST ORGANICHESKOGO SINTEZA AK
Publication of FR2437401A1 publication Critical patent/FR2437401A1/fr
Application granted granted Critical
Publication of FR2437401B1 publication Critical patent/FR2437401B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Abstract

LA PRESENTE INVENTION CONCERNE LA BIOCHIMIE, ET PLUS PRECISEMENT DE NOUVEAUX ANALOGUES CYCLIQUES DE LA CALLIDINE. CONFORMEMENT A L'INVENTION, LES ANALOGUES CYCLIQUES DE LA CALLIDINE REPONDENT A LA FORMULE GENERALE SUIVANTE: (CF DESSIN DANS BOPI) DANS LAQUELLE PRO EST UN RESTE DE LA L-PROLINE; GLY DE LA GLYCINE; PHE DE LA L-PHENYLALANINE; ARG DE LA L-ARGININE; R EST UN RESTE D'UN ACIDE A- OU O-AMINE OU D'UN PEPTIDE; R EST UN RESTE D'UN ACIDE A- OU O-AMINE; R EST LA L-SERINE OU LA GLYCINE; LE GROUPE CARBONYLE DE L'ARGININE ETANT LIE SOIT AVEC R, SOIT AVEC R PAR UNE LIAISON PEPTIDIQUE COVALENTE, ET LE CYCLE ETANT FORME EN UTILISANT LE GROUPE O-AMINO DE L'ACIDE AMINE EN POSITION 1 OU 2 DE LA SEQUENCE DE LA CALLIDINE. LES NOUVEAUX COMPOSES PROPOSES SONT DOTES D'UNE ACTIVITE BIOLOGIQUE ET PEUVENT TROUVER UNE APPLICATION DANS LA MEDECINE EN QUALITE DE SUBSTANCE ACTIVE DE PRODUITS MEDICAMENTEUX A ACTION HYPOTENSIVE PROLONGEE.
FR7924399A 1978-09-29 1979-10-01 Analogues cycliques de la callidine et leur application therapeutique Granted FR2437401A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU782699155A SU1219587A1 (ru) 1978-09-29 1978-09-29 Циклические аналоги каллидина и других пахикининов,обладающие пролонгированным гипотензивным действием в сочетании с низкой или полностью отсутствующей миотропной активностью

Publications (2)

Publication Number Publication Date
FR2437401A1 true FR2437401A1 (fr) 1980-04-25
FR2437401B1 FR2437401B1 (fr) 1983-11-18

Family

ID=20799586

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7924399A Granted FR2437401A1 (fr) 1978-09-29 1979-10-01 Analogues cycliques de la callidine et leur application therapeutique

Country Status (7)

Country Link
US (1) US4285857A (fr)
JP (1) JPS5573645A (fr)
BE (1) BE879088A (fr)
DE (1) DE2939522C2 (fr)
FR (1) FR2437401A1 (fr)
GB (1) GB2033397B (fr)
SU (1) SU1219587A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374060A (en) * 1981-07-15 1983-02-15 Merck & Co., Inc. Process for the preparation of cyclic hexapeptide
JPS6160699A (ja) * 1984-08-31 1986-03-28 Agency Of Ind Science & Technol 新規環状オクタペプチド,その製造方法及びそれを成分とする金属イオン抽出分離剤
ES2054011T3 (es) * 1988-09-05 1994-08-01 Sankyo Co Un proceso para la preparacion de un compuesto, "leualacina".

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889M (fr) * 1962-04-25 1964-11-02 Olin Mathieson Nouveau décapeptide désigné sous le nom de 7-glycine kallidine.
FR2411828A1 (fr) * 1977-12-14 1979-07-13 Inst Organicheskogo Sinteza Ak Analogue cyclique de la bradykinine, constitue par la cyclo- ((ne-1-llysine, 6-glycine)-bradykinine)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247181A (en) * 1960-09-01 1966-04-19 Ciba Geigy Corp Polypeptide derivatives and esters thereof
US3216992A (en) * 1962-04-16 1965-11-09 Olin Mathieson 7-glycine bradykinin and intermediates for the production thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889M (fr) * 1962-04-25 1964-11-02 Olin Mathieson Nouveau décapeptide désigné sous le nom de 7-glycine kallidine.
FR2411828A1 (fr) * 1977-12-14 1979-07-13 Inst Organicheskogo Sinteza Ak Analogue cyclique de la bradykinine, constitue par la cyclo- ((ne-1-llysine, 6-glycine)-bradykinine)

Also Published As

Publication number Publication date
JPS5573645A (en) 1980-06-03
GB2033397A (en) 1980-05-21
GB2033397B (en) 1982-11-03
FR2437401B1 (fr) 1983-11-18
US4285857A (en) 1981-08-25
SU1219587A1 (ru) 1986-03-23
BE879088A (fr) 1980-03-28
DE2939522C2 (de) 1982-03-18
DE2939522A1 (de) 1980-04-17

Similar Documents

Publication Publication Date Title
Vigneaud et al. The synthesis of an octapeptide amide with the hormonal activity of oxytocin
DE69829381T2 (de) Hepatitis c inhibitor peptide
Schröder et al. The Peptides: Methods of peptide synthesis
RU95112539A (ru) Новый полипептид и фармацевтическая композиция против вич-инфекции
Ranadive et al. Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors
DE69827956T2 (de) Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
KR890014578A (ko) 펩타이드 화합물, 이의 제조방법 및 이를 함유하는 약제학적 조성물
CA2064473A1 (fr) Acides amines chimeriques et peptides contenant ces analogues
DK222989A (da) Antiaggregatoriske peptider, farmaceutiske midler indeholdende peptiderne samt fremgangsmaader til anvendelse heraf
Bodanszky et al. Side reactions in peptide synthesis. 11. Possible removal of the 9-fluorenylmethyloxycarbonyl group by the amino components during coupling
JPH05506859A (ja) 血液―脳関門透過性の増加方法
ES2204713T3 (es) Inhibidores de proteasa ns3 de hcv.
JPS62270552A (ja) 新規ペプチド化合物
US3482025A (en) Glutathione-amino acid compositions,and glutathione-basic amino acid salts
RU2223970C2 (ru) Лечение ожирения
KR0155559B1 (ko) 신규한 펩티드, 및 그것을 함유하는 항치매제
FR2437401A1 (fr) Analogues cycliques de la callidine et leur application therapeutique
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
HUT76483A (en) Derivatives of gamma-amino-alfa,beta-alkenyl sulfonic acids, utilization of the same in the synthesis of pseudopeptides and process for their preparation
UA46725C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИМІКРОБНОЮ АКТИВНІСТЮ ТА ПОХІДНІ ДИПЕПТИДУ З <font face="Symbol">a</font>-АМІНОКИСЛОТИ АБО ЇЇ ПОХІДНОГО ТА ЦИКЛОПЕНТАН-<font face="Symbol">b</font>-АМІНОКИСЛОТИ АБО ЇЇ ПОХІДНОГО
KR920701244A (ko) 심실 펩티드 유도체
US4579841A (en) Dipeptide derivatives having opiate activity
Draper et al. Lipolytic activity of Met-Arg-His-Phe-Arg-Trp-Gly, a synthetic analog of the ACTH (4-10) core sequence
BE905974A (fr) Conjugue de l'alpha-melanotropine avec la p-l-sarcolysine.
US4278595A (en) Orally active MIF analogs with an effect on the central nervous system

Legal Events

Date Code Title Description
ST Notification of lapse